Crossmark

Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery

Crossref DOI link: https://doi.org/10.1186/s41512-019-0048-7

Published Online: 2019-02-14

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Perry, Andrew

Chung, Matthew J.

Novak, Eric

Krone, Ronald

Brown, David L. https://orcid.org/0000-0002-0930-9747
License Information

Text and Data Mining valid from 2019-02-14
More Information

Article History

Received: 11 September 2018

Accepted: 9 January 2019

First Online: 14 February 2019

Ethics approval and consent to participate

: The Human Research Protection Office at Washington University granted this study exemption from Institutional Review Board oversight. Patients enrolled in the original BARI 2D trial provided informed consent and the study received ethics approval at each of the enrolling sites.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.